September
Market Access NHS England: In conversation with Neil Grubert
How NHS England’s evolving priorities are reshaping market access and what Life Sciences teams need to do next
With NHS England continuing to evolve its structure, priorities and approach to value, understanding market access has never been more critical. Join Neil Grubert for a strategic update on access policy, payer expectations and evidence requirements heading into late 2026 and beyond.
October
The Impact of MFN & IRP on Access & Launch Sequencing
Master your global pricing strategy in the age of MFN and IRP
Global pricing pressures are intensifying, but are you prepared? In this timely 60-minute masterclass, Andrew Cummins reveals how Most Favoured Nation clauses and International Reference Pricing are driving price convergence – and the implications for launch sequencing, access and commercial success.